Caprio et al., 2021 - Google Patents
EZH2 is required for parathyroid and thymic development through differentiation of the third pharyngeal pouch endodermCaprio et al., 2021
View HTML- Document ID
- 15702737001794866068
- Author
- Caprio C
- Lania G
- Bilio M
- Ferrentino R
- Chen L
- Baldini A
- Publication year
- Publication venue
- Disease Models & Mechanisms
External Links
Snippet
The Ezh2 gene encodes a histone methyltransferase of the polycomb repressive complex 2 that methylates histone H3 lysine 27. In this study, we investigated whether EZH2 has a role in the development of the pharyngeal apparatus and whether it regulates the expression of …
- 101700041849 EZH2 0 title abstract description 177
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scavuzzo et al. | Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis | |
| Morita et al. | Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions | |
| Tosic et al. | Lsd1 regulates skeletal muscle regeneration and directs the fate of satellite cells | |
| Hämäläinen et al. | Tissue-and cell-type–specific manifestations of heteroplasmic mtDNA 3243A> G mutation in human induced pluripotent stem cell-derived disease model | |
| Gely-Pernot et al. | Retinoic acid receptors control spermatogonia cell-fate and induce expression of the SALL4A transcription factor | |
| Heo et al. | Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by antagonizing Dnmt3l | |
| Wang et al. | Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells | |
| Boulard et al. | FBXL10 protects Polycomb-bound genes from hypermethylation | |
| Chen et al. | Transcriptional control in cardiac progenitors: Tbx1 interacts with the BAF chromatin remodeling complex and regulates Wnt5a | |
| Sala et al. | The Stat3-Fam3a axis promotes muscle stem cell myogenic lineage progression by inducing mitochondrial respiration | |
| Robert-Finestra et al. | SPEN is required for Xist upregulation during initiation of X chromosome inactivation | |
| Wyler et al. | Pet-1 switches transcriptional targets postnatally to regulate maturation of serotonin neuron excitability | |
| Javed et al. | Microcephaly modeling of kinetochore mutation reveals a brain-specific phenotype | |
| Harris et al. | Transcriptional regulation of intermediate progenitor cell generation during hippocampal development | |
| Kawaue et al. | Lzts1 controls both neuronal delamination and outer radial glial-like cell generation during mammalian cerebral development | |
| Harada et al. | Histone H3. 3 sub-variant H3mm7 is required for normal skeletal muscle regeneration | |
| Caprio et al. | EZH2 is required for parathyroid and thymic development through differentiation of the third pharyngeal pouch endoderm | |
| Giafaglione et al. | Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment | |
| Mauri et al. | NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation | |
| Pensold et al. | The DNA methyltransferase 1 (DNMT1) controls the shape and dynamics of migrating POA-derived interneurons fated for the murine cerebral cortex | |
| Kitazawa et al. | A unique bipartite Polycomb signature regulates stimulus-response transcription during development | |
| Yelagandula et al. | ZFP462 safeguards neural lineage specification by targeting G9A/GLP-mediated heterochromatin to silence enhancers | |
| Zhang et al. | E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors | |
| Lépine et al. | Homozygous ALS-linked mutations in TARDBP/TDP-43 lead to hypoactivity and synaptic abnormalities in human iPSC-derived motor neurons | |
| Han et al. | Global translation during early development depends on the essential transcription factor PRDM10 |